Solutions for Cancer Targeted Therapy

Pan-cancer Comprehensive Genomic Profiling Platform

Cancer genetic test is an important method used by pharmaceutical companies to enroll clinical trial patients, study drug resistance mechanism research, and discover biomarker during the development of cancer targeted therapy. To meet the diverse research needs of researchers in these areas, Sequanta Technologies has established a comprehensive genomic profiling platform that covers different gene sizes, tumor types, and technical roadmaps. A comprehensive genomic profiling platform can meet different domestic and international regulatory requirements , ensuring that partners can select the product that best meets their clinical project needs and application scenarios to facilitate efficient research and rapid market launch of targeted drugs.

Product Features

Extensive product portfolio and customized solutions for partners

Pan-cancer Comprehensive genomic profiling platform of Sequanta Technologies covers relevant molecular alterations from multiple key oncology guidelines (NCCN, ESMO, ACMG, CSCO) and clinical trials for solid and hematologic tumors. It can detect molecular alterations such as point mutations, insertion-deletion variants, copy number variants, and fusion genes.

Covering biomarker in guidelines

The analysis platform covers a variety of tumor treatment guidelines (NCCN, ESMO, ACMG, CSCO), clinical trials and biomarkers of pathways related to tumorigenesis and development, maximizing the possibility of finding positive biomarkers from patient biopsies and providing customers and partners with higher quality biomarker detection services.

Service Advantages

Excellent product performance with strict validation

Pan-cancer comprehensive genomic profiling products of Sequanta Technologies have been validated by Sequanta Laboratories to meet CAP/CLIA standards, including accuracy studies, precision studies, and limit of detection studies, and have passed CAP, NCCL, SCCL, and other domestic and international inter-laboratory quality assessments with perfect scores, thus fully meeting the performance requirements of regulatory agencies for test in clinical trials .

Successful Cases